Summit Therapeutics Inc. (SMMT) stock
SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.50−0.17 (-1.59%)
Close on Nov 18, 2026Market cap $8.38BP/E –Yield –
Summit Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Summit Therapeutics's market cap was $13.20B on Nov 11, 2026, against $13.32B a year earlier. Over the last 5 years it ranged from $98.12M to $19.56B, with a median of $6.10B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.20B | +1.4% |
| 2025 | Dec 31, 2025 | $13.02B | -1.0% |
| 2024 | Dec 31, 2024 | $13.15B | +622.2% |
| 2023 | Dec 29, 2023 | $1.82B | +112.9% |
| 2022 | Dec 30, 2022 | $855.61M | +225.8% |
| 2021 | Dec 31, 2021 | $262.62M | +224.3% |
| 2020 | Dec 31, 2020 | $80.97M | +193.7% |
| 2019 | Dec 31, 2019 | $27.57M | +83.2% |
| 2018 | Dec 31, 2018 | $15.05M | -89.0% |
| 2017 | Dec 29, 2017 | $136.39M | +34.8% |
| 2016 | Dec 30, 2016 | $101.18M | – |
See a number that looks wrong?